Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.

Demel UM, Wirth M, Yousefian S, Zhang L, Isaakidis K, Dönig J, Böger M, Singh N, Köse H, Haas S, Müller S, Schick M, Keller U.

Open source

DOI
10.3324/haematol.2022.280995
Published
2023-02-01
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2022.280995,
  title = {Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.},
  author = {Demel UM and  Wirth M and  Yousefian S and  Zhang L and  Isaakidis K and  Dönig J and  Böger M and  Singh N and  Köse H and  Haas S and  Müller S and  Schick M and  Keller U.},
  year = {2023},
  journal = {Haematologica},
  doi = {10.3324/haematol.2022.280995},
  url = {https://doi.org/10.3324/haematol.2022.280995}
}

RIS

TY  - JOUR
TI  - Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.
AU  - Demel UM
AU  -  Wirth M
AU  -  Yousefian S
AU  -  Zhang L
AU  -  Isaakidis K
AU  -  Dönig J
AU  -  Böger M
AU  -  Singh N
AU  -  Köse H
AU  -  Haas S
AU  -  Müller S
AU  -  Schick M
AU  -  Keller U.
PY  - 2023
JO  - Haematologica
DO  - 10.3324/haematol.2022.280995
UR  - https://doi.org/10.3324/haematol.2022.280995
ER  - 

APA

UM, D., M, W., S, Y., L, Z., K, I., J, D., M, B., N, S., H, K., S, H., S, M., M, S., & U., K. (2023). Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.. Haematologica. https://doi.org/10.3324/haematol.2022.280995

Source records